Clinical Trial

Inhaled Sedation in Critically Ill Patients

Study acronym: IS-CRITIC
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The proposal of this study is to compare inhaled sedation with isoflurane administered via the Sedaconda ACD-S system with intravenous sedation with propofol. Patients will be randomized 1:1 to receive either inhaled sedation with isoflurane administered via the Sedaconda ACD device (Sedana Medical, Uppsala, Sweden) or intravenous propofol. The primary endpoint is the number of ventilator-free days at 28 days after randomization.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-05-24; most recent amendment 2026-06-26.
Status change: Not Yet Recruiting → Recruiting 2025-12-19
Trial Details
NCT Number NCT07000526
Lead Sponsor Instituto de Investigación Hospital Universitario La Paz
Collaborators: Instituto de Salud Carlos III
Conditions Sedation, Airway Extubation
Enrollment 620 participants
Start Date 2025-12-15
Primary Completion 2027-03 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-29